Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - May 2014

ELA: Advances in Cellular Assays & Cell Culture

14 May 2014 - 15 May 2014 - Barcelona, Spain

Bookmark and Share

SELECTBIO's Advances in Cellular Assays & Cell Culture conference will focus primarily on bio-processing technologies as well as applications.  Both up-stream and down-stream bio-processing are addressed and our focus in this track is to highlight technology trends, end-user application segments, and opportunities in the application of new approaches for addressing bottlenecks in bio-processing which currently exist. SELECTBIO highlights emerging companies in this conference track and we encourage submissions from start-up and new technology entrants.
 The second part of the Advances in Cellular Assays & Cell Culture conference track will focus upon new methodologies for cellular capture including emerging trends in flow cytometry—we seek to highlight in this segment the new instrumentation for flow cytometry and novel application areas.  Here also, we encourage submissions from start-up companies and new technology providers.

Together, this conference track seeks to bring together end-users as well as technology developers to address emerging applications in cellular analysis and bioprocessing deployment.

Running alongside the Advances in Cellular Assays & Cell Culture conference will be the ELA exhibition, covering the latest technological advances and associated services from leading solution providers within this field. Registered delegates will also have access to the following co-located conference tracks, ensuring a cost effective trip: Advances in NGS & Big Data, High Content Analysis, Advances in Automation & Robotics and Advances in qPCR & dPCR.

You can also present your research on a poster while attending the meeting. Submit an abstract for consideration now!
Poster Submission Deadline: 02 May 2014

Further information
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
A Cellular Symphony Responsible for Autoimmune Disease
Broad Institute researchers have used a novel approach to increase our understanding of the immune system as a whole.
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Editing of LIMS Data Made Faster and More Efficient in Matrix Gemini
The latest version of the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics now provides faster and more efficient editing of LIMS data by eliminating the need for a second editing screen.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Red Clover Genome to Help Restore Sustainable Farming
The Genome Analysis Centre (TGAC) in collaboration with IBERS, has sequenced and assembled the DNA of red clover to help breeders improve the beneficial traits of this important forage crop.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos